Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024148
Filing Date
2021-05-05
Accepted
2021-05-05 16:40:51
Documents
85
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sana-10q_20210331.htm   iXBRL 10-Q 2839837
2 EX-10.24 sana-ex1024_54.htm EX-10.24 48732
3 EX-31.1 sana-ex311_43.htm EX-31.1 21370
4 EX-31.2 sana-ex312_42.htm EX-31.2 19853
5 EX-32.1 sana-ex321_41.htm EX-32.1 10003
6 EX-32.2 sana-ex322_40.htm EX-32.2 9715
7 GRAPHIC g1gpgjfoow03000001.jpg GRAPHIC 54094
  Complete submission text file 0001564590-21-024148.txt   10245332

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA sana-20210331.xsd EX-101.SCH 62408
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sana-20210331_cal.xml EX-101.CAL 47775
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sana-20210331_def.xml EX-101.DEF 208787
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20210331_lab.xml EX-101.LAB 468691
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20210331_pre.xml EX-101.PRE 381974
13 EXTRACTED XBRL INSTANCE DOCUMENT sana-10q_20210331_htm.xml XML 2026959
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39941 | Film No.: 21894048
SIC: 2836 Biological Products, (No Diagnostic Substances)